枸橼酸莫沙必利联合磷酸铝治疗胆汁反流性胃炎的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of Mosapride Citrate combined with Aluminum Phosphate in the treatment of bile reflux gastritis.Methods A total of 86 cases of bile reflux gastritis treated in our hospital from January 14,2017 to January 20,2018 were selected as the subjects and divided into the control group (43 cases)and the observation group(43 cases)according to the random number method.The control group was treated with PPI combined with Mosapride Citrate,and the observation group was given the PPI and Mosapride Citrate combined with Aluminum Phosphate.The clinical total effective rate and clinical symptom score(anti acid,nausea,abdominal distention,heartburn,upper abdominal pain)and the incidence of adverse reactions(constipation,dry mouth,diarrhea)were compared between the two groups.Results The total effective rate of the observation group after treatment was 97.67%(42/43),which was higher than that of the control group of 72.09% (31/43),and the difference was statistically significant(P＜0.05).The clinical scores of the observation group(sour regurgitation of[0.56±0.12]points,nausea of[0.33±0.12]points,abdominal distension of[0.58±0.15]points,heartburn of[0.63±0.20]points and epigastric pain of[0.52±0.10]points)were lower than those in the control group(sour regurgitation of[1.63±0.36]points,nausea of[1.36±0.26]points,abdominal distention of[1.65±0.40]points,heartburn of[2.36±0.78]points and epigastric pain of[1.98±0.52]points),the differences were statistically significant(P＜0.05).The incidence of adverse reactions after treatment in the observation group was 2.33%(1/43),which was lower than that in the control group of 18.60%(8/43),and the difference was statistically significant(P＜0.05).Conclusion The combination of Mosapride Citrate and Aluminum Phosphate is of high clinical value in the treatment of bile reflux gastritis.It can reduce the incidence of adverse reactions on the basis of relieving clinical symptoms.It is worth applying and popularizing.

Key words： Mosapride Citrate Aluminum Phosphate Bile reflux gastritis Clinical effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SHEN Lin
	LAN Jian

Cite this article:

SHEN Lin,LAN Jian. Effect of Mosapride Citrate combined with Aluminum Phosphate on bile reflux gastritis[J]. 中国当代医药, 2018, 25(29): 124-126.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I29/124

[1]	李彤中，邢继军，闫纪琳，等.木瓜止痉汤结合脘腹6穴游走罐治疗胆汁反流性胃炎临床观察[J].河北医药，2016，38（22）：3445-3448.
[2]	黄璠，朱云清.熊去氧胆酸对原发性胆汁反流性胃炎的疗效观察[J].西南国防医药，2017，27（11）：1218-1220.
[3]	张晓慧.莫沙必利联合阿嗪米特治疗胆汁反流性胃炎的临床疗效观察[J].实用临床医药杂志，2015，19（21）：140-141.
[4]	葛彩霞.莫沙必利联合铝碳酸镁片治疗胆汁反流性胃炎疗效观察[J].北方药学，2017，14（8）：100-101.
[5]	王文文，王军，娄海奎.莫沙必利等三联药物治疗胆汁反流性胃炎药学探讨[J].北方药学，2017，14（10）：74-75.
[6]	黄衔，钟志旭.基于四磨汤的四联用药治疗胆囊切除术后胆汁反流性胃炎的效果观察[J].广东医学，2017，38（S1）：271-273.
[7]	盛尧慧，桂若虎，郑新平，等.莫沙必利联合铝碳酸镁片用于胆汁反流性胃炎患者治疗中的效果分析[J].当代医学，2016，22（30）：149-150.
[8]	华德林，许建中，董一飞，等.熊去氧胆酸钠治疗胆汁反流性胃炎的疗效及胃内24 h胆汁的影响观察[J].中国中西医结合消化杂志，2015，23（4）：273-275.
[9]	孙天燕，张克宁，高小毛，等.康复新液治疗胆汁反流性胃炎的临床疗效[J].中国中西医结合消化杂志，2016，24（9）：712-714.
[10]	钱浩.铝碳酸镁联合多潘立酮治疗胆囊切除后胆汁反流性胃炎的疗效评价[J].实用临床医药杂志，2017，21（19）：66-69.
[11]	林勇，叶丹，施正超.埃索美拉唑、多潘立酮与铝碳酸镁联合治疗胆汁反流性胃炎的临床疗效[J].中华全科医学，2016，14（3）：409-411.
[12]	赵铁葆.贝母瓜蒌散联合奥美拉唑治疗反流性咽喉炎[J].长春中医药大学学报，2015，31（4）：759-761.
[13]	楚加元，贾华锋.莫沙必利联合铝碳酸镁治疗胆汁返流性胃炎效果分析[J].海南医学，2017，28（13）：2183-2185.
[14]	杨凡，龚瑞雪.埃索美拉唑联合枸橼酸莫沙必利对哮喘合并胃食管反流患者肺功能的影响[J].实用临床医药杂志，2016，20（13）：155-156.
[15]	王薇，石蕾，许乐，等.马来酸曲美布汀治疗老年反流性食管炎患者中的疗效观察[J].中华老年医学杂志，2016，35（5）：511-516.